James Archie Jr Harrell
CIK 1738462 · Chief Commercial Officer · last filed 2021-12-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$542.7K
Companies
3
Total Filings
11
Lifetime Open-Market Net
$91.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Chief Commercial Officer | 36,766 | $14.76 | $542.7K | $1.7K | 1 | 2021-12-14 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Chief Commercial Officer | 35,673 | $2.93 | $104.5K | $90.1K | 9 | 2021-06-14 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Exec. VP, Mktg & External Comm | — | — | — | $0 | 1 | 2018-05-08 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-08 | Avalo Therapeutics, Inc. (CERCW) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.